When a condition is rare, the small number of real cases is swamped by the false positives drawn from the much larger healthy group — so a test with high sensitivity and high specificity still returns more wrong positives than right ones.

A positive only becomes more likely true than false once prevalence exceeds the break-even level fixed by the false-positive rate — below that line, specificity governs the answer and raising sensitivity barely moves it.